Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | PPM1D | O15297 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5512052 | 0.80 | PPM1D (0.33) | CTSSCTSKPPM1D | |
| SCHEMBL1867461 | 0.80 | PPM1D (0.33) | CTSSCTSKPPM1D | |
| SCHEMBL4970239 | 0.78 | CNR2 (0.38) | CTSSCTSKPPM1D | |
| SCHEMBL3594507 | 0.78 | CNR2 (0.38) | CTSSCTSKPPM1D | |
| SCHEMBL1872191 | 0.74 | CTSK (0.39) | CTSSCTSK | |
| SCHEMBL973034 | 0.74 | REN (0.33) | CTSS | |
| SCHEMBL2080298 | 0.73 | CTSS (0.32) | CTSSCTSK | |
| SCHEMBL20981637 | 0.73 | PPM1D (0.34) | CTSSCTSKPPM1D | |
| SCHEMBL19945738 | 0.73 | PPM1D (0.34) | CTSSCTSKPPM1D | |
| SCHEMBL28676436 | 0.71 | PPM1D (0.33) | PPM1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110105506-A1 | Diaminoalkane aspartic protease inhibitors | VITAE PHARMACEUTICALS, INC. | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105506-A1 | Diaminoalkane aspartic protease inhibitors | DNPEP, PEPD, ACE | CTSS 138/4885CTSK 31/4885PPM1D 1440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.